QT Imaging Holdings (QTIH) AI Stock Analysis

• Market Cap: $81.71M
• Dividend Yield: N/A
• Average Volume (3M): 31.43K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.14
• Revenue Growth: 168.52%
• EPS Growth: 12.22%
• Country: US
• Employees: N/A
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical Equipment & Supplies
• EPS (TTM): -0.47
• Shares Outstanding: 11,893,778
• 10 Day Avg. Volume: 22,708
• 30 Day Avg. Volume: 31,432
• PEG Ratio: 0.00
• Price to Book (P/B): 0.00
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: 0.50
• Enterprise Value/Revenue: 5.47
• Enterprise Value/Gross Profit: 9.56
• Enterprise Value/Ebitda: -9.59
• 1Y Price Target: $3.40
• Price Target Upside: -47.69% Downside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 28 Underperform
• Price Target: ―

QT Imaging Holdings presents significant financial challenges, with negative profit margins and high leverage being the most critical factors. The bearish technical indicators and concerning valuation metrics further weigh on the stock's outlook. However, the recent corporate event showcasing innovative technology offers some potential upside, although overall risks remain high.

QT Imaging Holdings Business Overview & Revenue Model

Company Description

QT Imaging Holdings (QTI) is a medical technology company that specializes in developing and providing advanced imaging solutions. The company operates primarily in the healthcare sector, focusing on innovative non-invasive imaging technologies that enhance diagnostic capabilities. Their core product offerings include high-resolution imaging systems designed to improve patient outcomes by providing clearer and more accurate diagnostic images.

How the Company Makes Money

QT Imaging Holdings makes money through the sale and leasing of its imaging equipment to healthcare providers, including hospitals, clinics, and diagnostic centers. Additionally, the company may generate revenue from service agreements for maintenance and support of their imaging systems. QTI could also engage in strategic partnerships or collaborations with other medical technology companies to expand their market reach and drive sales. Revenue may also be supplemented by research and development grants, as well as potential licensing of their proprietary imaging technologies to third parties.

QT Imaging Holdings Financial Statement Overview

Summary

QT Imaging Holdings is currently facing a challenging financial situation. Despite a positive revenue growth trajectory, the company struggles with profitability and sustainability, as highlighted by negative profit margins and high leverage. The reliance on external financing to maintain operations and a negative stockholders' equity position emphasize the potential risks and need for strategic improvements.

Income Statement

QT Imaging Holdings has shown a significant increase in revenue over the TTM period, moving from zero to $4,032,168, indicating a positive growth trajectory. However, the company is struggling with profitability, as evidenced by negative profit margins: Gross Profit Margin at 53.4%, Net Profit Margin at -375.3%, and negative EBIT and EBITDA margins, indicating substantial operational losses.

Balance Sheet

The balance sheet reveals a highly leveraged position with a negative stockholders' equity of -$9,651,660, resulting in an undefined Debt-to-Equity Ratio. The negative equity ratio highlights potential solvency issues, while assets have decreased significantly. The company's high debt level poses a significant risk.

Cash Flow

Cash flow analysis indicates negative free cash flow growth, with TTM free cash flow deteriorating further to -$9,461,768. The operating cash flow to net income ratio is 0.62, reflecting operational cash constraints. The company is heavily reliant on financing activities to support cash requirements, as seen from significant financing cash flow.

Breakdown	TTM	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	7.41M	0.00	708.24K	365.15K
Gross Profit	4.24M	0.00	151.32K	104.58K
EBITDA	-4.23M	-3.39M	-2.26M	-4.27M
Net Income	-7.62M	-5.13M	-6.26M	-5.42M
Balance Sheet
Total Assets	11.63M	23.40M	7.75M	8.46M
Cash, Cash Equivalents and Short-Term Investments	2.04M	2.44K	455.08K	1.53M
Total Debt	4.82M	3.07M	7.86M	4.23M
Total Liabilities	11.96M	12.69M	9.26M	5.52M
Stockholders Equity	-324.29K	10.71M	-1.51M	2.94M
Cash Flow
Free Cash Flow	-6.88M	-1.94M	-3.88M	-2.72M
Operating Cash Flow	-6.83M	-1.94M	-3.86M	-2.70M
Investing Cash Flow	-54.43K	19.92M	-22.60K	-18.37K
Financing Cash Flow	4.70M	-18.05M	2.78M	3.67M

QT Imaging Holdings Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 6.50
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For QTIH, the sentiment is Negative. The current price of 6.5 is below the 20-day moving average (MA) of 6.67, below the 50-day MA of 7.06, and above the 200-day MA of 4.02, indicating a neutral trend. The MACD of -0.07 indicates Positive momentum. The RSI at 45.15 is Neutral, neither overbought nor oversold. The STOCH value of 26.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for QTIH.

QT Imaging Holdings Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
LUNG	46 Neutral	$70.08M	-1.20	-66.88%	―	18.24%	4.81%
MDAI	45 Neutral	$60.46M	-2.82	―	―	22.27%	49.22%
ICCM	40 Underperform	$47.34M	-2.50	-230.80%	―	-16.46%	4.14%
ALGS	38 Underperform	$44.35M	-0.36	-141.82%	―	-55.88%	6.14%
JSPR	35 Underperform	$49.70M	―	-146.87%	―	―	-17.96%
QTIH	28 Underperform	$81.71M	-3.24	-1536.16%	―	168.52%	12.22%